Bioavailability of SC Formulation and Japanese Ethnobridging Study for PRA023

Conditions

• Healthy

Interventions

• DRUG: PRA023 IV Low Dose
• DRUG: PRA023 SC
• DRUG: Placebo IV
• DRUG: Placebo SC
• DRUG: PRA023 IV High Dose

Sponsor

Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Collaborators

• [object Object]